Search hospitals
>
California
>
Los Angeles
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
Claim this profile
Los Angeles, California 90048
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Brain Tumor
Conducts research for Prostate Cancer
99 reported clinical trials
21 medical researchers
Summary
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center is a medical facility located in Los Angeles, California. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Brain Tumor, Prostate Cancer and other specialties. Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center is involved with conducting 99 clinical trials across 185 conditions. There are 21 research doctors associated with this hospital, such as Andrew Hendifar, MD, Monica Mita, MD, Jun Gong, MD, and Jeremy D. Rudnick.
Area of expertise
Lung Cancer
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center has run 22 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center has run 15 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Andrew Hendifar, MD
Cedars-Sinai Medical Center
6 years of reported clinical research
Monica Mita, MD
Cedars-Sinai Medical Center
9 years of reported clinical research
Jun Gong, MD
Cedars-Sinai Medical Center
4 years of reported clinical research
Jeremy D. Rudnick
Cedars-Sinai Medical Center
4 years of reported clinical research
Clinical Trials running at Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
Pancreatic Cancer
Lung Cancer
Myelofibrosis
Breast Cancer
Breast cancer
Cancer
Non-Small Cell Lung Cancer
Solid Tumors
Glioblastoma
Brain Tumor
Azeliragon
for Refractory Pancreatic Cancer
This is an open label study to determine the safety and preliminary evidence of a therapeutic effect of azeliragon in patients refractory to prior treatment of metastatic pancreatic cancer.
Recruiting
1 award
Phase 1 & 2
8 criteria
APL-101
for Lung Cancer
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting
1 award
Phase 2
11 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center?
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center is a medical facility located in Los Angeles, California. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Brain Tumor, Prostate Cancer and other specialties. Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center is involved with conducting 99 clinical trials across 185 conditions. There are 21 research doctors associated with this hospital, such as Andrew Hendifar, MD, Monica Mita, MD, Jun Gong, MD, and Jeremy D. Rudnick.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.